company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4020000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8137000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,529000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12686000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12686000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,55000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,35000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1391000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1371000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11315000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11315000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11315000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11315000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27600000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27600000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.41
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27623297.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 16:21:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3892000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8862000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,511000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13265000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13265000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,66000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,33000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2059000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2092000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15357000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15357000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15357000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15357000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27400000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.56
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27400000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.56
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27625137.0
Amicus Therapeutics Inc,FOLD,,0001178879,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 10:53:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.56
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5966000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5966000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5966000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4402000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11125000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,438000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15965000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9999000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,48000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,59000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3362000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3351000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13350000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13350000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13350000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13350000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34200000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34200000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34498926.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 18:00:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.39
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4040000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4040000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4040000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6720000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11618000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,426000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18764000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14724000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,41000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,46000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2078000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2083000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12641000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12641000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12641000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12641000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34200000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34200000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.37
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34530693.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 18:03:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5798000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5798000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5798000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4841000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13711000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,380000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18932000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13134000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,32000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3376000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3375000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9759000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9759000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9759000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9759000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34900000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34900000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34979702.0
Amicus Therapeutics Inc,FOLD,,0001178879,2011.0,Q3,2011-07-01,2011-09-30,2011-11-02 10:53:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7774000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7774000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7774000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4095000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14004000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,420000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18519000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10745000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,43000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,27000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2376000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2392000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13137000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13137000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13137000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13137000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37500000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37500000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37887520.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 18:00:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10637000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10637000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10637000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5819000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13723000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,442000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19984000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9347000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,116000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-97000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9343000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9343000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9343000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9343000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46700000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46700000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46870067.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 18:03:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4995000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11499000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,422000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16916000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16916000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,92000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,553000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,626000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16290000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16290000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16290000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16290000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47900000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47900000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48513647.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:42:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4455000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11047000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,421000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15923000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15923000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,81000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2594000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2663000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13260000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3245000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10015000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10015000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10015000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45600000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45600000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45565217.0
Amicus Therapeutics Inc,FOLD,,0001178879,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4823000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11989000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,439000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17251000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17251000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,65000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-262000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-207000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17458000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17458000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17458000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17458000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49900000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49900000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49621188.0
Amicus Therapeutics Inc,FOLD,,0001178879,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 17:02:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,475000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,475000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,475000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4753000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9978000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,396000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-81000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-305000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14741000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14266000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,374000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,36000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-338000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14604000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-10000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14614000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14614000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14614000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,66400000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66400000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67212764.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:07:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,293000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,293000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,293000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5270000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12049000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,375000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,15000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-600000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17109000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16816000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,377000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,55000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-322000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17138000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-11000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17149000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17149000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17149000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,78000000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,78000000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,78889346.0
Amicus Therapeutics Inc,FOLD,,0001178879,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 08:37:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6427000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16113000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,508000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,10000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1000000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24058000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24058000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,372000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,171000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-201000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24259000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-29000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24288000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24288000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24288000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97200000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,97200000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,95743416.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:50:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8278000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17234000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,353000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,952000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,26000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,100000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26943000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26943000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,338000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,158000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-180000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27133000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-10000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27143000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27133000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27133000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100500000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100500000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,99994125.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 11:28:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15372000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20971000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,395000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,7000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1300000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38045000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38045000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,316000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,299000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37800000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-54000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37854000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37800000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37800000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,118100000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118100000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,118724882.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 14:18:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17192000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22625000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,577000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-952000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-28000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1977000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41391000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41391000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,851000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,284000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1032000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1599000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-42926000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,93000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42833000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42897000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-42897000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,110100000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,110100000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109923815.0
Amicus Therapeutics Inc,FOLD,,0001178879,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15701000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23425000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,673000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,50000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,3152000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43001000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-43001000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,945000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,307000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-638000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-43691000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-52000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43743000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43691000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-43691000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,124800000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,124800000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,125178517.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 10:35:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19300000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18281000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,767000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,8000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,10186000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48542000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-48542000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1055000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,331000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2237000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2961000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-51503000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-453000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51050000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-51050000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-51050000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,127600000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,127600000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,129122175.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 11:50:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2127000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2127000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,344000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,344000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1783000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17469000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32457000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,896000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,11000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-4110000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46723000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-44940000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1517000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,460000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-910000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1967000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-46907000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-253000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-46654000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46654000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-46654000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,141400000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,141400000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,140656109.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:06:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2831000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2831000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,489000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,489000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2342000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18681000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30630000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,906000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-2468000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47749000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-45407000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1881000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,504000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-14948000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16325000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-61680000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3033000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,52000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-58595000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-58647000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-58647000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,134300000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,134300000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.41
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,134401588.0
Amicus Therapeutics Inc,FOLD,,0001178879,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4169000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4169000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,775000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,775000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3394000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19132000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30876000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,823000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4578000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55409000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-52015000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4290000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,759000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,610000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2921000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-54936000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,56000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54992000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54992000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-54992000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,141000000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,141000000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,142770629.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 14:31:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.39
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7158000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7158000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1061000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1061000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6097000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19311000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31985000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,812000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1050000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53158000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-47061000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4179000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,753000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2400000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1026000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-48087000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,49000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-48136000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48136000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-48136000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,141600000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,141600000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,143000718.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 10:56:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10874000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10874000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1790000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1790000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9084000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21647000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40641000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,851000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,465427000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-244250000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,284316000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-275232000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4351000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1190000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2044000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1117000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-276349000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-164683000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-111666000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-111666000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-111666000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,161800000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.69
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,161800000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.69
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,160796841.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 14:56:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.69
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14729000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14729000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2610000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2610000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12119000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,28581000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45808000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,1107000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4300000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79796000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-67677000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4420000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1394000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,954000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2072000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-69749000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-541000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-69208000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-69208000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-69208000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,153500000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.43
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,153500000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.43
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,153355144.0
Amicus Therapeutics Inc,FOLD,,0001178879,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.43
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16696000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16696000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2615000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2615000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14081000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27396000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40798000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,969000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1100000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,70263000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-56182000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4488000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1737000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7625000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4874000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-51308000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1392000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49916000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49916000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-49916000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,178300000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,178300000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,175977700.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 17:27:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21309000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21309000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3135000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3135000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18174000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29172000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34660000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,973000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,300000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65105000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-46931000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4560000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2913000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-12916000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14563000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-61494000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,339000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61833000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61833000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-61833000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,187400000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,187400000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,188621423.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:17:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20596000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20596000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4310000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4310000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16286000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,31867000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,138227000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,1073000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1300000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,172467000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-156181000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4715000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2721000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1039000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3033000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-159214000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-51000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-159163000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-159163000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-159163000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,189500000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.84
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,189500000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.84
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,189162841.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:46:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.84
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32644000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32644000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4344000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4344000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28300000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,38765000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,57217000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,1201000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,600000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,97783000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-69483000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8639000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3090000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2041000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7590000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-77073000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1010000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-78083000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-78083000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-78083000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,185600000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.43
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,185600000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.43
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,185790021.0
Amicus Therapeutics Inc,FOLD,,0001178879,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.43
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,34046000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,34046000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4055000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4055000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29991000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44303000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,64593000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,991000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1383000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,111270000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-81279000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6454000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2639000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-35037000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-38852000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-120131000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,168000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-120299000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-120299000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-120299000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,214800000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.56
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,214800000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.56
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,213519287.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:30:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.56
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44130000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44130000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5367000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5367000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38763000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42578000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,70981000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,1154000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,480000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,115193000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-76430000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4625000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2599000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5378000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7404000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-83834000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,717000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-84551000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-84551000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-84551000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,234900000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,234900000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,238089824.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:17:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48768000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48768000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5596000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5596000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43172000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39680000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,58892000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,1116000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,789000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,100477000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-57305000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4026000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2752000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3481000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4755000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-62060000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-251000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61809000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61809000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-61809000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,257500000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,257500000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,254674422.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:46:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,55293000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,55293000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6945000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6945000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,48348000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43300000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,91912000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,1514000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,645000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,137371000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-89023000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3767000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2259000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,646000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-862000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-89885000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-156000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-89729000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-89729000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-89729000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,240800000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,240800000.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,240421001.0
Amicus Therapeutics Inc,FOLD,,0001178879,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
